ANEBULO PHARMACEUTICALS, INC. Entity Listing, Par Value Per Share
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Entity Listing, Par Value Per Share of $0.00 per share for the 6-month period ending 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-02-12
- ANEBULO PHARMACEUTICALS, INC. entity listing, par value per share for the quarter ending 2025-09-30 was $0.00, a 0.00% change year-over-year.
- ANEBULO PHARMACEUTICALS, INC. entity listing, par value per share for the quarter ending 2024-09-30 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. entity listing, par value per share for fiscal 2024 was $0.00.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-Q · filed 2026-02-12 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | $0.00 10-K · filed 2024-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |